CAI
Caris Life Sciences, Inc. · Healthcare · Market cap $6.9B
Insiders sold $13.8M net in the last 90 days ·1 seller, 1 buyer· latest Form 4 filed Sep 4, 2026
Insider Buying
$1.6M
reported purchases (SEC code P)
Insider Selling
$16.5M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Sep 4, 2026
Spetzler David Baxley
Caris Life Sciences, Inc. (CAI) has 34 SEC Form 4 filings (42 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Sep 4, 2026.
Inside the rolling window, 5 insiders at Caris Life Sciences, Inc. reported 4 open-market purchases totaling $1.6M and 3 open-market sales totaling $16.5M. The most active filer is President Spetzler David Baxley with 3 filings. Insiders have net sold $13.3M over the trailing 6 months. The most recent open-market filing is a sale of 478,000 shares by President Spetzler David Baxley, dated Sep 3, 2026, worth $11.9M.
- Industry:Biotechnology
- CEO:David Dean Halbert
- Employees:1,846
- HQ:Irving, TX, US
- IPO:2025-06-18
| Source | |||||||
|---|---|---|---|---|---|---|---|
Spetzler David BaxleyFirst in 10 months | President | Sale | 478,000 | $11.9M | Sep 4 | -2.9% | SEC ↗ |
Spetzler David BaxleyFirst in 10 months | President | Sale | 119,212 | $3.0M | Sep 4 | -2.9% | SEC ↗ |
HALBERT JONFirst filing | Director | Purchase | 68,000 | $990K | Jul 13 | +42.7% | SEC ↗ |
Vacirca Jeff LFirst filing | Director | Purchase | 31,050 | $501K | May 12 | +45.2% | SEC ↗ |
Power Luke ThomasFirst filing | See Remarks | Sale | 62,250 | $1.7M | Dec 12 | -9.0% | SEC ↗ |
Denton John RusselFirst filing | See Remarks | Purchase | 4,184 | $101K | Nov 10 | -1.9% | SEC ↗ |
Spetzler David BaxleyFirst filing | President | Purchase | 400 | $10K | Nov 10 | -1.9% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does CAI have?
Caris Life Sciences, Inc. (CAI) has 34 SEC Form 4 filings (42 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Sep 4, 2026.
When was the most recent SEC Form 4 filing for CAI?
The most recent Form 4 filing for CAI on Tracefour is dated Sep 4, 2026.
Who is the most active insider at CAI?
The most active SEC Form 4 filer at CAI in the rolling window is President Spetzler David Baxley, with 3 filings.
What is the net insider flow at CAI over the last 6 months?
Over the trailing 180 days, insiders at CAI have net sold $13.3M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at CAI in the current window?
Inside the rolling window, insiders at CAI bought $1.6M and sold $16.5M based on SEC Form 4 filings.
Can I get alerts for CAI insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Caris Life Sciences, Inc. (CAI). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Caris Life Sciences, Inc. is in the Healthcare sector.